This application package invites small business concerns to submit a Phase II application for the Small Business Innovation Research Program (CFDA 84.133). This is in response to P.L. 106-554 , the "Small Business Reauthorization Act of 2000, H.R. 5667" (the "Act") enacted on December 21, 2000. The Act requires certain agencies, including the Department of Health and Human Services to establish a Small Business Innovation Research program to reserve a statutory percentage of their extramural research and development budgets to be award to small business concerns for research or research and development through a uniform, highly competitive, three-phase process each fiscal year. This is a discretionary grant which falls under the streamlined clearance process for discretionary grant Information Collection Requests (0985-0051).
The application /respondents number has been reduced due to requirements related to SBA rules for SBIR phase I, thus reducing the number of eligible applicants.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.